Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020 2020-11-16 21:00
PharmAbcine to participate at BIO-Europe 2020 2020-10-23 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020 2020-09-14 20:00
PharmAbcine is presenting at the KSMO 2020 2020-09-02 21:00
PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line 2020-09-02 21:00
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS 2020-08-18 21:00
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC 2020-08-03 21:00
PharmAbcine Signs Long-term Contract Manufacturing Organization Agreement for Olinvacimab with Binex 2020-06-27 00:00
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I 2020-06-11 00:00
PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas 2020-06-04 00:00
1 2 3